Predictions
Moderna Inc.
Start price
Target price
Perf. (%)
€127.18
05.12.20
05.12.20
-
05.12.21
05.12.21
18.07%
10.02.21
10.02.21
Significant cyclical dependencies
Higher risks for its business
American Airlines Group Inc.
Start price
Target price
Perf. (%)
€13.68
05.12.20
05.12.20
-
05.12.21
05.12.21
28.84%
24.02.21
24.02.21
Higher risks for its business
Below average Management
Occidental Petroleum Corp.
Start price
Target price
Perf. (%)
€15.30
05.12.20
05.12.20
€20.00
05.12.21
05.12.21
70.94%
06.12.21
06.12.21
Could be very worthwhile Investment >20% year
Trevena Inc.
Start price
Target price
Perf. (%)
€49.08
04.12.20
04.12.20
€55.00
28.04.21
28.04.21
23.84%
09.02.21
09.02.21
Could be very worthwhile Investment >20% year
Ferroglobe plc
Start price
Target price
Perf. (%)
€1.48
04.12.20
04.12.20
-
04.12.21
04.12.21
251.35%
05.12.21
05.12.21
Could be worthwhile Investment >10% per year
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Bio Path Holdings
Start price
Target price
Perf. (%)
€2.80
04.12.20
04.12.20
-
04.12.21
04.12.21
-81.43%
05.12.21
05.12.21
Probably not worthwhile Investment
Revenue decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
Ralph Lauren A
Start price
Target price
Perf. (%)
€80.18
03.12.20
03.12.20
-
03.12.21
03.12.21
27.96%
04.12.21
04.12.21
Could be worthwhile Investment >10% per year
Top 10 in its market
Small cyclical dependencies
Well known brand
Best Buy Co.
Start price
Target price
Perf. (%)
€87.65
03.12.20
03.12.20
-
03.12.21
03.12.21
6.42%
24.02.21
24.02.21
Revenue growth >5% per year expected
EBIT growth >5% per year expected
High dividend yield expected
Well known brand
Coca-Cola Co.
Start price
Target price
Perf. (%)
€43.09
03.12.20
03.12.20
-
03.12.21
03.12.21
10.93%
04.12.21
04.12.21
Could be worthwhile Investment >10% per year
Market Leader or Top 3
Well known brand
Future proof or reliable business model
Catabasis Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€11.72
02.12.20
02.12.20
-
02.12.21
02.12.21
-39.70%
03.12.21
03.12.21
Could be worthwhile Investment >10% per year
Salesforce.com
Start price
Target price
Perf. (%)
€193.98
02.12.20
02.12.20
-
02.12.21
02.12.21
6.12%
17.02.21
17.02.21
Could be worthwhile Investment >10% per year
Very capable Management
Market Leader or Top 3
Very Future proof/growth oriented business model
MSCI Inc. A
Start price
Target price
Perf. (%)
€343.60
01.12.20
01.12.20
-
01.12.21
01.12.21
1.83%
06.03.21
06.03.21
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Low dividend yield expected
Corbus Pharmaceuticals Holding Inc.
Start price
Target price
Perf. (%)
€46.50
01.12.20
01.12.20
€90.00
01.12.21
01.12.21
-27.97%
14.12.20
14.12.20
Could be worthwhile Investment >10% per year
Very bad culture
No uniques
Below average Management
Mccormick & Comp.
Start price
Target price
Perf. (%)
€80.99
01.12.20
01.12.20
€95.00
01.12.21
01.12.21
-4.16%
02.12.21
02.12.21
positive Cash Flow expected
Could be very worthwhile Investment >20% year
EBIT growth >5% per year expected
Revenue growth >5% per year expected
Waste Management Inc.
Start price
Target price
Perf. (%)
€100.34
01.12.20
01.12.20
€105.00
01.12.21
01.12.21
42.22%
02.12.21
02.12.21
Market Leader or Top 3
Well known brand
Very Future proof/growth oriented business model
Increased challenges to pay loans and raise capital
Enzon Pharmaceuticals
Start price
Target price
Perf. (%)
€0.12
01.12.20
01.12.20
€0.000
01.12.21
01.12.21
49.17%
14.12.20
14.12.20
Could be worthwhile Investment >10% per year
Larimar Therapeutics Inc.
Start price
Target price
Perf. (%)
€17.12
01.12.20
01.12.20
€20.00
01.12.21
01.12.21
5.26%
14.12.20
14.12.20
Could be worthwhile Investment >10% per year
Jaguar Health Inc.
Start price
Target price
Perf. (%)
€85.50
01.12.20
01.12.20
€225.00
01.12.21
01.12.21
-28.42%
14.12.20
14.12.20
Could be worthwhile Investment >10% per year
Entegris Inc.
Start price
Target price
Perf. (%)
€79.00
01.12.20
01.12.20
€140.00
23.02.22
23.02.22
43.04%
06.01.22
06.01.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
positive Cash Flow expected
Small cyclical dependencies
ShiftPixy Inc.
Start price
Target price
Perf. (%)
€202.00
30.11.20
30.11.20
€400.00
30.11.21
30.11.21
1.98%
14.12.20
14.12.20
Could be worthwhile Investment >10% per year
Genmark Diagnostics
Start price
Target price
Perf. (%)
€11.10
30.11.20
30.11.20
€14.00
30.11.21
30.11.21
-7.21%
14.12.20
14.12.20
Could be worthwhile Investment >10% per year
Pacific Biosciences of California Inc.
Start price
Target price
Perf. (%)
€13.50
30.11.20
30.11.20
€15.00
30.11.21
30.11.21
31.85%
14.12.20
14.12.20
Could be worthwhile Investment >10% per year
Cutera Inc.
Start price
Target price
Perf. (%)
€21.00
30.11.20
30.11.20
€25.00
30.11.21
30.11.21
-15.71%
14.12.20
14.12.20
Could be very worthwhile Investment >20% year